Abiopharma

New Form 8-K - REVIVA PHARMACEUTICALS HOLDINGS, INC. Filed: 2025-06-26 AccNo: 0001437749-25-021361 Size: 818 KB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits